Neglected Tropical Disease Treatment Market

May 2021| MRS227A| Market Research Studies

Report Highlights

The report focused on the different diseases of neglected tropical disease and the type of drugs and vaccines used for treating the disease. The report also focuses on the initiatives takes by the government and non-government regulatory authorities. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for neglected tropical disease treatment market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each by disease, product type, route of administration, end-user and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional neglected tropical disease treatment markets; it explains the major market drivers of the global neglected tropical disease treatment industry, current trends within the industry, major applications, and the regional dynamics of the global neglected tropical disease treatment market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global neglected tropical disease treatment market.

Report Includes

  • 41 tables and 49 figures
  • An up-to-date analysis of the Global Neglected Tropical Disease Treatment Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Neglected Tropical Disease Treatment Market, and corresponding market share analysis by disease, product type, route of administration, end-user, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Neglected Tropical Disease Treatment, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new vaccines, and drugs still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Neglected Tropical Disease Treatment Market as compared to overall global economy.
  • Insight into the growth development strategies of major Neglected Tropical Disease Treatment manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including F. Hoffmann-La Roche AG, Sanofi S.A., Eisai Co. Ltd., Pfizer, Inc., Novartis International AG, GlaxoSmithKline plc, Bayer AG, Abbott Laboratories, and others.

Summary

Neglected tropical diseases (NTDs) are a varied group of infections found mostly in the tropical region such as, some of the regions of Africa, America, and even Asia’s. These diseases are mainly caused by different kinds of pathogens which include, bacteria, protozoa, viruses, many others. WHO stated that neglected tropical diseases affects approximately 1 billion people or even more in the poor population. It has been observed that the low or middle-income countries have higher prevalence of these diseases due to lack of proper health facilities.


Various governmental and non-governmental agencies are working to aid building a strong health infrastructure for the faster and easy delivery of drugs in regions which are affected by NTDs. For instance, the World Health Organization Division of Control of Neglected Tropical Disease aids in organizing relief efforts and funds for the infected areas.

WHO proposes five core policies to tackle the problem of NTDs: individual disease management, preventive chemotherapy, vector control, sanitation and hygiene (WASH), and veterinary public health and water.

The Global Neglected Tropical Disease Treatment Market was valued at $2.18 billion in 2020 and is anticipated to witness a stable growth at a CAGR of 10.2% during the projected period.

  • Table 1 : Global Neglected Tropical Disease Treatment Market, Through 2026
  • Table 2 : Global Neglected Tropical Disease Treatment Market, by Disease, Through 2026
  • Table 3 : Global Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
  • Table 4 : Global Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
  • Table 5 : Global Neglected Tropical Disease Treatment Market, by End-User, Through 2026
  • Table 6 : Global Neglected Tropical Disease Treatment Market, by Region, Through 2026
  • Table 7 : North America Neglected Tropical Disease Treatment Market, by Disease, Through 2026
  • Table 8 : North America Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
  • Table 9 : North America Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
  • Table 10 : North America Neglected Tropical Disease Treatment Market, by End-User, Through 2026
  • Table 11 : North America Neglected Tropical Disease Treatment Market, by Country, Through 2026
  • Table 12 : Europe Neglected Tropical Disease Treatment Market, by Disease, Through 2026
  • Table 13 : Europe Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
  • Table 14 : Europe Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
  • Table 15 : Europe Neglected Tropical Disease Treatment Market, by End-User, Through 2026
  • Table 16 : Europe Neglected Tropical Disease Treatment Market, by Country, Through 2026
  • Table 17 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Disease, Through 2026
  • Table 18 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
  • Table 19 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
  • Table 20 : Asia-Pacific Neglected Tropical Disease Treatment Market, by End-User, Through 2026
  • Table 21 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Country, Through 2026
  • Table 22 : South America Neglected Tropical Disease Treatment Market, by Disease, Through 2026
  • Table 23 : South America Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
  • Table 24 : South America Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
  • Table 25 : South America Neglected Tropical Disease Treatment Market, by End-User, Through 2026
  • Table 26 : South America Neglected Tropical Disease Treatment Market, by Country, Through 2026
  • Table 27 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Disease, Through 2026
  • Table 28 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
  • Table 29 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
  • Table 30 : Middle East & Africa Neglected Tropical Disease Treatment Market, by End-User, Through 2026
  • Table 31 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Country, Through 2026
  • Table 32 : F. Hoffmann-La Roche AG: Financial Performance, Through 2020
  • Table 33 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 34 : Eisai Co. Ltd.: Financial Performance, Through 2020
  • Table 35 : Pfizer, Inc.: Financial Performance, Through 2020
  • Table 36 : Novartis International AG: Financial Performance, Through 2020
  • Table 37 : GlaxoSmithKline plc: Financial Performance, Through 2020
  • Table 38 : Bayer AG: Financial Performance, Through 2020
  • Table 39 : Abbott Laboratories: Financial Performance, Through 2020
  • Table 40 : StratifiCare Pte. Ltd.: Financial Performance, Through 2020
  • Table 41 : Takeda Pharmaceutical Company Limited: Financial Performance, Through 2020
  • Figure 1 : Global Neglected Tropical Disease Treatment Market
  • Figure 2 : Global Neglected Tropical Disease Treatment Market, by Value, 2019-2026
  • Figure 3 : Global Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
  • Figure 4 : Global Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
  • Figure 5 : Global Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
  • Figure 6 : Global Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
  • Figure 7 : Global Neglected Tropical Disease Treatment Market, by Value, by Region, 2020
  • Figure 8 : Global Neglected Tropical Disease Treatment Market, by Value, by Company, 2020
  • Figure 9 : Global Neglected Tropical Disease Treatment Market, Product Map, 2020
  • Figure 10 : North America Neglected Tropical Disease Treatment Market, by Value, 2019-2026
  • Figure 11 : North America Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
  • Figure 12 : North America Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
  • Figure 13 : North America Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
  • Figure 14 : North America Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
  • Figure 15 : North America Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
  • Figure 16 : Europe Neglected Tropical Disease Treatment Market, by Value, 2019-2026
  • Figure 17 : Europe Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
  • Figure 18 : Europe Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
  • Figure 19 : Europe Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
  • Figure 20 : Europe Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
  • Figure 21 : Europe Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
  • Figure 24 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
  • Figure 25 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
  • Figure 26 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
  • Figure 27 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
  • Figure 28 : South America Neglected Tropical Disease Treatment Market, by Value, 2019-2026
  • Figure 29 : South America Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
  • Figure 30 : South America Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
  • Figure 31 : South America Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
  • Figure 32 : South America Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
  • Figure 33 : South America Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
  • Figure 36 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
  • Figure 37 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
  • Figure 38 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
  • Figure 39 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
  • Figure 40 : F. Hoffmann-La Roche AG: Revenue Share, 2020
  • Figure 41 : Sanofi S.A.: Revenue Share, 2020
  • Figure 42 : Eisai Co. Ltd.: Revenue Share, 2020
  • Figure 43 : Pfizer, Inc.: Revenue Share, 2020
  • Figure 44 : Novartis International AG: Revenue Share, 2020
  • Figure 45 : GlaxoSmithKline plc: Revenue Share, 2020
  • Figure 46 : Bayer AG: Revenue Share, 2020
  • Figure 47 : Abbott Laboratories: Revenue Share, 2020
  • Figure 48 : StratifiCare Pte. Ltd.: Revenue Share, 2020
  • Figure 49 : Takeda Pharmaceutical Company Limited: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report